Nectar Lifescience informs about disclosures

04 Apr 2025 Evaluate

With reference to point no. 2 of Annexure 1 of letter no. NLL/CS/2024-438 dated November 22, 2024, vide which the Company had informed pending Litigation(s) as required under Regulation 30 of the LODR Regulations. Pursuant to captioned regulations, Nectar Lifescience has informed that it enclosed necessary disclosures in prescribed format for details/ updation of Litigation and/ or orders passed by any regulatory authority or judicial body as per Annexure-A. The relevant extract of letter no. NLL/CS/2024-438 dated November 22, 2024, is attached as an Annexure B.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

14.58 0.69 (4.97%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×